How a discovery in Yellowstone National Park led to the development of PCR - Richmond Scientific
A discovery in Yellowstone National Park led to the development of PCR, the gold-standard COVID-19 tests used to fight the global pandemic.
Reminder: Nobel-prize winning PCR (1983), used in basically all genetic tech today, was only possible because of extremophile bacterium discovered in 1964 in Yellowstone funded by a small ~$80k NSF grant with no obvious application at the time. #science π§ͺ
www.richmondscientific.com/how-a-discov...
08.06.2025 21:09 β π 1235 π 524 π¬ 22 π 30
NIH's work saves livesβ& Trump is gutting it.
Straight from D.C. I headed to Seattle Children's to hear from researchers & patients alike about the importance of NIH fundingβit's not just about lines in a budget, it's about lifesaving discoveries.
We ALL need to speak up to save it.
02.05.2025 21:04 β π 741 π 191 π¬ 29 π 14
We havenβt done anisotropic, which is a good idea since labeling the arrestins isnβt much of an issue. We do observe differences between different receptors in terms of their recruitment of different orientations of oligomers.
10.04.2025 18:18 β π 1 π 0 π¬ 0 π 0
Thanks!
10.04.2025 18:16 β π 0 π 0 π¬ 0 π 0
We are doing some experiments now where we induce dimerization of beta arrestins before receptor activation. Depending on the orientation of the dimers, it can inhibit its function. But it looks like certain orientations function just as well as WT arrestins.
09.04.2025 16:50 β π 1 π 0 π¬ 1 π 0
We think this finding may explain how beta-arrestins interact with a wide range of proteins and how they may organize signaling at the receptor. This is just the start! We are currently performing additional experiments and MD simulations to model these potential interactions.
09.04.2025 00:46 β π 2 π 0 π¬ 0 π 0
Consistent with this, we found that a constitutionally active ADGRE1 (ADGRE1-b β lacking most of the extracellular domain but maintain the tethered agonist sequence) promoted condensates, unlike the apo receptor (ADGRE1 FL) or a receptor without tethered agonist (ADGRE-1 bT).
09.04.2025 00:46 β π 3 π 0 π¬ 2 π 0
While the beta-arrestins in this 2:2 complex were not directly interacting, they were in a conformation that could promote an N-N interaction that was identified through metadynamics. This suggested that receptor activation could promote beta-arrestin oligomerization.
09.04.2025 00:46 β π 2 π 0 π¬ 1 π 0
Serendipitously, Peng Xiao and Jinpeng Sun solved the structure of an adhesion receptor that forms tight complexes with beta-arrestins. Surprisingly, this structure displayed a 2:2 complex with the beta-arrestin at a unique angle compared to other GPCR:beta-arrestin structures.
09.04.2025 00:46 β π 2 π 0 π¬ 1 π 0
Previous work from the Marullo, Benovic, and Gurevich labs identified specific sites in beta-arrestins that bind inositol hexaphosphate (IP6) to regulate beta-arrestin oligomerization. We found those mutations impacted beta-arrestin-dependent internalization and GPCR signaling.
09.04.2025 00:46 β π 2 π 0 π¬ 1 π 0
We then used an optogenetic approach to test if these were consistent with condensates. When Cry2 undergoes light-induced oligomerization, the presence of specific sequences (such as IDRs) leads to condensate formation (see FUSN). Beta-arrestin 1 had a similar effect!
09.04.2025 00:46 β π 2 π 0 π¬ 1 π 0
We performed FRAP that demonstrated that proteins in these puncta exchanged with solution, although with slightly slower kinetics than beta-arrestin 2 in the cytosol.
09.04.2025 00:46 β π 2 π 0 π¬ 1 π 0
It has been known for decades that beta-arrestins oligomerize, but the relevance of this in a cellular context is unknown. Labeling beta-arrestin 2 with GFP results in a cytoplasmic pattern, while labeling with components of split GFP results in punctae, consistent with oligomers.
09.04.2025 00:46 β π 2 π 0 π¬ 1 π 0
Killing Cancer Patients (Once the Payments Clear)
'Speeds things up, you know. Move fast and break things, amIright?
Problem is, in biomedicine some of the things you break are human beings.'
@dereklowe.bsky.social
www.science.org/content/blog...
02.02.2025 11:11 β π 39 π 18 π¬ 0 π 2
Merck stopped the Phase 3 Hyperion trial of its pulmonary arterial hypertension (PAH) treatment Winrevair early due to strong efficacy data & fiercepharma.com/pharma/effic... all study participants will be offered access to the drug. #biosky 1/n
30.01.2025 22:51 β π 5 π 3 π¬ 1 π 1
American science and medicine has been thrown into chaos and uncertainty over the past week. Here are some stories to get up to speed. 1/12
28.01.2025 03:58 β π 1843 π 1155 π¬ 63 π 189
Started off this morning emailing my Senators and Congressman about the NIH and the potential damage being done by unnecessary disruptions.
They need to hear from us loud and clear. Constituents matter to them as one of the primary purposes of a politician is to get re-elected (and its their job).
23.01.2025 11:26 β π 315 π 131 π¬ 11 π 11
a cartoon says hey everybody an old man 's talking while bart simpson looks on
ALT: a cartoon says hey everybody an old man 's talking while bart simpson looks on
Bluetorial: When the leadership of Science magazine does not seem to care about getting the facts right in a news story...
A very troubling incident occurred some years ago and I think the concerns and lessons are important.
My apologies for the length, but it is a complicated story.
17.01.2025 15:13 β π 120 π 43 π¬ 9 π 16
This is usually the premise behind a horror movieβ¦
04.01.2025 23:45 β π 0 π 0 π¬ 1 π 0
Similar finding with resolution of chest pain after stress test or cathβ¦
27.11.2024 19:55 β π 2 π 1 π¬ 1 π 0
Design of allosteric modulators that change GPCR G protein subtype selectivity
G protein-coupled receptors (GPCRs), the largest family of drug targets, can signal through 16 subtypes of GΞ± proteins. Biased compounds that selectively activate therapy-relevant pathways promise to ...
Can we design allosteric modulators that change a GPCR's preferred G protein? Yes!π₯
BAMs at the GPCR-transducer interface change G protein subtype selectivity in predictable ways, enabling rational drug design.
The lab's 1st preprint! Check it out! π§ͺππ§ π¦https://doi.org/10.1101/2024.11.20.624209
π§΅π
22.11.2024 16:08 β π 81 π 20 π¬ 7 π 2
We have updated and expanded our database of fellowships for POSTDOCS in neuroscience/neurology/cog science.
For each fellowship, we provide a description, $ amount, deadline, link, and eligibility criteria.
Download our database freely here: research.jhu.edu/rdt/funding-... pic.x.com/eEhXhlOzEj
24.11.2024 22:35 β π 80 π 48 π¬ 2 π 0
UCSF postdoc in the von Zastrow lab - interested in the intersection of GPCR biology and neuroscience π§ π¬π©βπ¬
Molecular Biologist (aemonten.github.io) δΈ¨Chief Editor @ CSH Protocols (cshprotocols.cshlp.org) δΈ¨Head of the Integrity in Publishing Group at CSHL Press δΈ¨Chair "Molecular Biosystems Conference" (molbiosystems.com) δΈ¨(Oxford) Comma King δΈ¨Central Dogma Police
Pulmonary Vascular Research Institute (PVRI) is a global medical organisation focused on the improvement of care and awareness of pulmonary vascular diseases.
PhD Student in Integrative structural biology on RNA-binding proteins.
#crystallography #SAXS #NMR #RNA #biophysics #biochemistry #structuralbiology
Exploring #ComputationalBiology & #Bioinformatics + Documenting my learning journey | Built by @noureldenrihan.bsky.social | π djosergenomics.github.io
Assistant Professor at UMich with a focus on computational pharmacology (he/him)
Medical doctor, endocrinologist turned into pharmacologist, loves #GPCRs and #biophysics, jazz music, good wine. Opinions my own.
The official account for American Heart Association meetings, science news, funding opportunities and membership.
Internist at Baylor College of Medicine, Houston
#EP NPπ funny heart rhythms and #CIED devices
Mom, Christian, lover of puns.
Amateur curler π₯ and pickleball
Kindness to all humans β€οΈ
#CardioSky #Epeeps #MedSky #HRS #NP
Are you a Duke physician-scientist? We can connect you to mentoring, funding, and more. Visit our website to see how many ways we can help. Success starts here.
Website: medschool.duke.edu/opsd
Postdoc in membrane protein structural biology & drug design
Research Assistant Professor of Biochemistry and Biophysics | Director, Johnson Foundation Biophysics and Structural Biology Core Facility | Univ of PA | he/him
PhD candidate and Teaching Associate at Moansh University | Drug Discovery Biology | GPCR Biology | Cryo-EM | Short-Term Research Scholar at Pfizer
Cardiac Surgeon & Informatician, Oregon Health & Science University | Faculty, OHSU Surgical Data & Decision Sciences Lab
Postdoctoral researcher @ Monash University (Stone Lab).
Multiomics (CRISPR, proteomics), GPCR signalling networks, leukocyte chemotaxis, and bioinformatics.
Reposting anything I find cool!